These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8205803)

  • 1. Extension of one-sided test to multiple treatment trials.
    Chen TT; Simon RM
    Control Clin Trials; 1994 Apr; 15(2):124-34. PubMed ID: 8205803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multiple decision procedure in clinical trials.
    Chen TT; Simon R
    Stat Med; 1994 Mar 15-Apr 15; 13(5-7):431-46. PubMed ID: 8023027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiple-step selection procedure with sequential protection of preferred treatments.
    Chen TT; Simon R
    Biometrics; 1993 Sep; 49(3):753-61. PubMed ID: 8241371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials.
    Rewari AN; Haffty BG; Wilson LD; Son YH; Joe JK; Ross DA; Papac RJ; Sasaki CT; Fischer JJ
    Cancer J; 2006; 12(2):123-9. PubMed ID: 16630403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations.
    Bourhis J; Etessami A; Wilbault P; Lusinchi A; Calais G; Lapeyre M; Pignon JP
    Curr Opin Oncol; 2004 May; 16(3):215-9. PubMed ID: 15069315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.
    Kiyota N; Tahara M; Okano S; Kawashima M; Matsuura K; Onozawa Y; Nibu K; Hayashi R; Yoshimura K; Ohtsu A
    Jpn J Clin Oncol; 2012 Oct; 42(10):927-33. PubMed ID: 22923484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is nutrition support related to a poor prognosis in head and neck cancer patients? Thoughts about the secondary analysis of RTOG trial 90-03.
    Sanabria A; Carvalho AL; Kowalski LP
    Head Neck; 2007 May; 29(5):518-9; author reply 519-20. PubMed ID: 17390379
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic decision making in stages III and IV head and neck squamous cell carcinoma.
    Gleich LL; Collins CM; Gartside PS; Gluckman JL; Barrett WL; Wilson KM; Biddinger PW; Redmond KP
    Arch Otolaryngol Head Neck Surg; 2003 Jan; 129(1):26-35. PubMed ID: 12525191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.
    Szturz P; Wouters K; Kiyota N; Tahara M; Prabhash K; Noronha V; Castro A; Licitra L; Adelstein D; Vermorken JB
    Oncologist; 2017 Sep; 22(9):1056-1066. PubMed ID: 28533474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the relation between improved loco-regional control and disease-free survival in head-and-neck cancer.
    Håkansson K; Rasmussen JH; Bentzen SM; Friborg J; Specht L; Vogelius IR
    Acta Oncol; 2019 Mar; 58(3):390-392. PubMed ID: 30764696
    [No Abstract]   [Full Text] [Related]  

  • 11. Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis.
    Winquist E; Oliver T; Gilbert R
    Head Neck; 2007 Jan; 29(1):38-46. PubMed ID: 17103410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial.
    Magrini SM; Buglione M; Corvò R; Pirtoli L; Paiar F; Ponticelli P; Petrucci A; Bacigalupo A; Crociani M; Lastrucci L; Vecchio S; Bonomo P; Pasinetti N; Triggiani L; Cavagnini R; Costa L; Tonoli S; Maddalo M; Grisanti S
    J Clin Oncol; 2016 Feb; 34(5):427-35. PubMed ID: 26644536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing temporal agreement between central and local progression-free survival times.
    Zeng D; Cornea E; Dong J; Pan J; Ibrahim JG
    Stat Med; 2015 Feb; 34(5):844-58. PubMed ID: 25393731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.
    Pignon JP; Bourhis J; Domenge C; Designé L
    Lancet; 2000 Mar; 355(9208):949-55. PubMed ID: 10768432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using routine data to estimate survival and recurrence in head and neck cancer: our preliminary experience in twenty patients.
    Liu ZW; Fitzke H; Williams M
    Clin Otolaryngol; 2013 Aug; 38(4):334-9. PubMed ID: 23621396
    [No Abstract]   [Full Text] [Related]  

  • 16. Value of information methods to design a clinical trial in a small population to optimise a health economic utility function.
    Pearce M; Hee SW; Madan J; Posch M; Day S; Miller F; Zohar S; Stallard N
    BMC Med Res Methodol; 2018 Feb; 18(1):20. PubMed ID: 29422021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancer.
    Blanchard P; Hill C; Guihenneuc-Jouyaux C; Baey C; Bourhis J; Pignon JP;
    J Clin Epidemiol; 2011 Sep; 64(9):985-92. PubMed ID: 21330105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options.
    Strojan P; Ferlito A; Langendijk JA; Corry J; Woolgar JA; Rinaldo A; Silver CE; Paleri V; Fagan JJ; Pellitteri PK; Haigentz M; Suárez C; Robbins KT; Rodrigo JP; Olsen KD; Hinni ML; Werner JA; Mondin V; Kowalski LP; Devaney KO; de Bree R; Takes RP; Wolf GT; Shaha AR; Genden EM; Barnes L
    Head Neck; 2013 Feb; 35(2):286-93. PubMed ID: 22034062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trials 6: On contamination and estimating the actual treatment effect.
    Parfrey PS
    Methods Mol Biol; 2015; 1281():249-59. PubMed ID: 25694314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial design limitations in head and neck squamous cell carcinomas.
    Yun HJ; Bogaerts J; Awada A; Lacombe D
    Curr Opin Oncol; 2007 May; 19(3):210-5. PubMed ID: 17414638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.